Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 23, 2026 14:00 ET | Source: Coherus Oncology, Inc.

Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)

REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. (“Zumutor”), an immuno-oncology biotech company, today announced a clinical...
June 23, 2026 09:43 ET | Source: X-tosis

X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson's Disease Therapy

GAINESVILLE, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- X-tosis Receives Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Novel Parkinson's Disease Therapy. The ward...
June 22, 2026 08:30 ET | Source: BioMedWire

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage...
June 22, 2026 08:30 ET | Source: Entera Bio Ltd.

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to...
June 22, 2026 06:45 ET | Source: Magna Mining Inc.

Magna Mining Intersects 29.7% Copper Equivalent over 3.4 metres, consisting of 9.4% Copper, 2.3% Nickel, 19.8 g/t Gold and 8.8 g/t Platinum + Palladium within the R2 Footwall Zone at the Levack Mine in Sudbury, Ontario

SUDBURY, Ontario, June 22, 2026 (GLOBE NEWSWIRE) -- Magna Mining Inc. (TSXV: NICU) (OTCQX: MGMNF) (FSE: 8YD) (“Magna” or the “Company”) is pleased to provide the results of ongoing exploration and...
June 19, 2026 06:31 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
June 19, 2026 06:31 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple

Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple
June 18, 2026 19:00 ET | Source: TermPlus

Australian Retirees Look to Leverage Retirement Capital To Generate Reliable Monthly Income - TermPlus June 2026 Two-Year Fixed-Term Account Delivers 8.00%* Per Annum

Sydney, Australia, June 18, 2026 (GLOBE NEWSWIRE) -- Australia's retiree population continues to grow. Around 4.4 million Australians are now aged 65 and over. That's about 17% of the population,...
June 18, 2026 09:01 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer

OCALA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final subject has received their first dose in the Phase 2...
June 18, 2026 08:30 ET | Source: MAIA Biotechnology, Inc.

MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University

Georgia’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center; well recognized at the forefront of cancer innovation and discovery nationwide CHICAGO, June 18, 2026 (GLOBE...